FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Add All Lorcaserin Drugs to List of Drugs Not to Compound: Public Citizen

Public Citizen says FDA should adopt a policy that whenever it announces that a drug has been withdrawn for reasons of safety or effectiveness, it wil...

Human Drugs

Braintree Wants Restrictions on Tablet Colonoscopy Prep

Braintree asks FDA to require particular specifications for any colonoscopy preparation tablet citing its Sutab as the reference-listed drug.

Human Drugs

5th Circuit Backs FTC in Impax Reverse Payment Case

The 5th Circuit Court of Appeals says FTC acted correctly in issuing a cease-and-desist order to Impax preventing any future reverse payment settlemen...

Human Drugs

Warning Sent to Maison Terre After Infant Death

FDA sends a Warning Letter to Maison Terre after conducting testing on its drug product labeled as Goldenseal Root Powder Organic and determining the ...

Human Drugs

Senate Approves FDA Active Moiety Definition

Attorney Andrew Goldfarb says Senate passage of a bill to codify in law FDAs active moiety definition for Waxman-Hatch five-year new active ingredient...

Federal Register

Comments on Ranking Antimicrobial Use in Animals

Federal Register notice: FDA reopens the comment period on an 11/16/2020 public meeting that requested public input on a potential revised approach fo...

Federal Register

Stakeholders Wanted for Generic Animal User Fee Reauthorization

Federal Register notice: FDA requests that public stakeholders notify it if they want to participate in periodic consultation meetings on reauthorizin...

Federal Register

Stakeholders Sought on Animal User Fee Reauthorization

Federal Register notice: FDA requests that public stakeholders notify it if they want to participate in periodic consultation meetings on reauthorizin...

Human Drugs

Woodcock Announces Cavazzoni as CDER Head

FDA acting commissioner Janet Woodcock announces that CDER deputy director for operations Patrizia Cavazzoni has been appointed CDER director.

Medical Devices

Medtronic Thoracic Stent Class 1 Recall

FDA classifies as Class 1 a Medtronic recall of all unused Valiant Navion thoracic stent grafts due to stent fractures and endoleak concerns.